Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This article outlines a withdrawal framework using index funds and bonds, covering order of withdrawals, sequence risk, and practical steps.
28,655 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
With a 15-day deadline to resolve Iran tensions, U.S. markets brace for a volatile April as traders weigh oil, stocks...
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...
Stocks trim gains as a risk-on mood cools. The Nasdaq Composite weakens, while tech names temper their rally as trade...
As Nasdaq volatility surges amid broader market jitters, one sub-$20 tech stock with a near-monopoly in a niche data ...
A mega-cap AI stock has defied the hype by turning into the unexpected bargain of the Magnificent Seven. Learn what t...
Anthropic has filed a confidential S-1, triggering a summer wave of AI IPO chatter. Private-market dynamics, competit...
June delivered a sharp pause as the Magnificent Seven shed trillions, signaling a shift toward chipmakers and AI infr...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...
A sharp intraday slide in D-Wave Quantum shares has many investors rattled. This guide breaks down what caused the mo...
As markets wobble in mid-2026, experts say retirees face a bigger threat from unplanned time than from lack of funds....
Syracuse reports a 30% drop in snow-complaint calls after deploying live GPS, dashcams, and AI. Officials say transpa...